E-medys (Cervval group, Brest) has developed Imago, an application for self-monitoring diabetes, laureate of the Digital for Life device by Atlanpole Thérapies and Images & Réseaux.
The start-up has been selected by the University Hospital of Brest and CHIC Quimper and has received a grant of €56 k to finalise the development of this application that allows diabetic patients to appropriate their medical protocol by applying it to an interactive avatar.
In the future, Imago will integrate a dimension of artificial intelligence to allow personalised adjustment of the treatment.
E-Medys, which has just joined the Village by CA du Finistère, works closely with the Cervval team. The start-up made Imago’s technology available for gestational diabetes remote monitoring.
Source : Lettre API – 04/07/2018
Photo credit : E-medys